Abstract:The aim of this study is to determine the relationships of vitamin D with diabetes, insulin resistance obesity, and metabolic syndrome. Intra cellular vitamin D receptors and the 1-α hydroxylase enzyme are distributed ubiquitously in all tissues suggesting a multitude of functions of vitamin D. It plays an indirect but an important role in carbohydrate and lipid metabolism as reflected by its association with type 2 diabetes (T2D), metabolic syndrome, insulin secretion, insulin resistance, polycystic ovarian syndrome, and obesity. Peer-reviewed papers, related to the topic were extracted using key words, from PubMed, Medline, and other research databases. Correlations of vitamin D with diabetes, insulin resistance and metabolic syndrome were examined for this evidence-based review. In addition to the well-studied musculoskeletal effects, vitamin D decreases the insulin resistance, severity of T2D, prediabetes, metabolic syndrome, inflammation, and autoimmunity. Vitamin D exerts autocrine and paracrine effects such as direct intra-cellular effects via its receptors and the local production of 1,25(OH)2D3, especially in muscle and pancreatic β-cells. It also regulates calcium homeostasis and calcium flux through cell membranes, and activation of a cascade of key enzymes and cofactors associated with metabolic pathways. Cross-sectional, observational, and ecological studies reported inverse correlations between vitamin D status with hyperglycemia and glycemic control in patients with T2D, decrease the rate of conversion of prediabetes to diabetes, and obesity. However, no firm conclusions can be drawn from current studies, because (A) studies were underpowered; (B) few were designed for glycemic outcomes, (C) the minimum (or median) serum 25(OH) D levels achieved are not measured or reported; (D) most did not report the use of diabetes medications; (E) some trials used too little (F) others used too large, unphysiological and infrequent doses of vitamin D; and (G) relative paucity of rigorous clinical data on the effects of vitamin D sufficiency on non-calcium endpoints. Although a large number of observational studies support improving T2D, insulin resistance, obesity, and metabolic syndrome with vitamin D adequacy, there is a lack of conclusive evidence from randomized control clinical trials that, these disorders are prevented following optimization of serum levels of 25(OH)D. However, none of the currently conducted clinical studies would resolve these issues. Thus, specifically designed, new clinical studies are needed to be conducted in well-defined populations, following normalizing the serum vitamin D levels in vitamin D deficient prediabetes subjects, to test the hypothesis that hypovitaminosis D worsens these disorders and correction would alleviate it.

Role of Vitamin D in Cardiometabolic Diseases

Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension, Atherosclerosis, and Heart Failure

Vitamin D and Cardiovascular Risk in Children.

Vitamin D Deficiency (VDD): the Culprit of Cardiometabolic Diseases?

Vitamin D as a modulator of molecular pathways involved in CVDs: Evidence from preclinical studies

Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes

Vitamin D's Role in Cardiovascular Diseases

Role of Vitamin D Deficiency in the Pathogenesis of Cardiovascular and Cerebrovascular Diseases

Vitamin D And Chronic Diseases

Effects of Vitamin D on Cardiovascular Risk and Oxidative Stress

Role of Vitamin D in the Metabolic Syndrome

The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art

The vitamin D system: a crosstalk between the heart and kidney

Low Serum 25-Hydroxyvitamin D Levels Are Associated with Increased Cardiovascular Morbidity and Mortality

Vitamin D Deficiency, Obesity And Diabetes

The role of functional vitamin D deficiency and low vitamin D reservoirs in relation to cardiovascular health and mortality

Vitamin D: A Bridge between Kidney and Heart

Analysis of Hot Trends in Research on the Association Between Vitamin D and Cardiovascular Disease.

Correlation between vitamin D metabolic pathway-related gene polymorphisms and cardiovascular disease

Vitamin D, Gut Microbiota, and Cardiometabolic Diseases-A Possible Three-Way Axis

Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome